BioLine RX Ltd - ADR (BLRX) is lower by Monday morning, with the stock decreasing -6.04% in pre-market trading to 1.4. BLRX's short-term technical score of 75 indicates that the stock has traded more bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, BioLine RX Ltd - ADR ranks higher than 89% of stocks. BioLine RX Ltd - ADR has fallen 28.71% over the past month, closing at $2.03 on September 11. During this period of time, the stock fell as low as $1.45 and as high as $2.33. BLRX has an average analyst recommendation of Strong Buy. The company has an average price target of $14.00.
News Home
BioLine RX Ltd - ADR has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Biotechnology industry which is number 135 by this metric, BLRX ranks better than 135% of stocks.
BioLine RX Ltd - ADR (BLRX) has fallen 6.04% Monday In Premarket Trading
Mentioned in this article
BLRX has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on BLRX!